Image

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD

Recruiting
All
Phase 1

Powered by AI

Overview

The bulk of dry eye patients are found in the community. The lack of satisfactory protocols and confidence is a significant deterrent for practitioners to manage such patients, which may result in inaccurate referrals, and unhappy patients. Problems are compounded by comorbidities of dry eye, even if these are not diagnosed formally.

Aligning with the healthcare strategy to move beyond healthcare to health, and beyond hospital care to community care, investigators propose that the confidence of primary carers be increased by using an image-based screening system.

This study aim to determine the efficacy of this screening AI algorithm, a prototype, in addition to or instead of screening of dry eye using a simple DEQ-5 symptom questionnaire.

Description

Investigators have shown that a single corneal picture after dye staining can detect DED that are ideally managed at tertiary care because these require prescription eyedrops. The main type of DED patients that respond to cyclosporine eyedrops are those with severe cornea staining. In collaboration with data scientists from ASTAR, the preliminary data involving more than 1000 images from China and Singapore show that this artificial intelligence-based screening is sensitive and specific.

By reducing unnecessary referrals to hospitals, investigators will make healthcare more sustainable and affordable. Previously, patients in the community are evaluated purely based on subjective symptoms. investigators not only standardize this with a validated and short DEQ5 questionnaire, but evaluate the accuracy of screening is improved by using the AI algorithms on the corneal image, a prototype, in addition to the DEQ5, and in place of the DEQ5.

Aim: Determine the efficacy of this screening AI algorithm, a prototype, in addition to or instead of screening of dry eye using a simple DEQ-5 symptom questionnaire.

Rationale: DEQ-5 is aimed to detect dry eye cases, but not necessarily dry eye requiring specialist care. The AI algorithm picks up cases with central cornea staining, which can then be referred for specialist care. Non-referred cases can be managed with eyelid warming, artificial tears and advice, with the aim of rescreening at a later time.

Eligibility

Inclusion Criteria:

  1. 21 years old and above
  2. Participants must be previously diagnosed with dry eye in the dry eye clinic (previous referred and had various forms of treatment such as artificial tears or prescription eyedrops)
  3. Willing to perform all eye examinations and questionnaires in this study
  4. Ability to provide informed consent

Exclusion Criteria:

  1. All subjects meeting any of the exclusion criteria at baseline will be excluded from participation and then list the criterion.
  2. Any other specified reason as determined by clinical investigator

Study details
    Chronic Kidney Diseases

NCT05018845

The Foundation for Orthopaedics and Regenerative Medicine

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.